- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.02 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 3 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
EPE.2: 5 residues within 4Å:- Chain A: W.148, G.152, F.153, P.154, K.155
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.155
- Water bridges: A:N.156
EPE.6: 5 residues within 4Å:- Chain B: W.148, G.152, F.153, P.154, K.155
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:K.155
EPE.9: 5 residues within 4Å:- Chain C: W.148, G.152, F.153, P.154, K.155
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:K.155
- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 5 residues within 4Å:- Chain A: R.171, H.186
- Chain C: L.183, S.184, H.186
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain A- Water bridges: C:L.183, C:A.207, A:R.171, A:H.186
- Salt bridges: C:H.186, A:R.171, A:H.186
SO4.12: 6 residues within 4Å:- Chain B: L.183, S.184, H.186
- Chain D: R.171, H.186, W.188
6 PLIP interactions:2 interactions with chain B, 4 interactions with chain D- Water bridges: B:A.207, D:R.171, D:V.270
- Salt bridges: B:H.186, D:R.171, D:H.186
- 4 x D4S: (6R)-6-(3-aminophenyl)-3-[(2-chlorophenyl)sulfanyl]-4-hydroxy-6-(thiophen-3-yl)-5,6-dihydro-2H-pyran-2-one(Non-covalent)
D4S.4: 15 residues within 4Å:- Chain A: V.31, N.138, L.165, D.166, R.169, H.193, G.194, D.195, V.235, A.238, Y.239, I.242, Y.247, T.248
- Ligands: NAI.1
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:A.238, A:I.242, A:I.242
- Hydrogen bonds: A:N.138, A:H.193, A:T.248, A:T.248
- Salt bridges: A:R.169
- pi-Stacking: A:Y.239
D4S.7: 15 residues within 4Å:- Chain B: V.31, N.138, L.165, D.166, R.169, H.193, G.194, V.234, V.235, A.238, Y.239, I.242, Y.247, T.248
- Ligands: NAI.5
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:A.238, B:I.242
- Hydrogen bonds: B:N.138, B:H.193, B:T.248, B:T.248, B:T.248
- Salt bridges: B:R.169
- pi-Stacking: B:Y.239
D4S.10: 15 residues within 4Å:- Chain C: V.31, N.138, D.166, R.169, H.193, G.194, D.195, V.234, V.235, A.238, Y.239, I.242, Y.247, T.248
- Ligands: NAI.8
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:V.235, C:A.238, C:I.242, C:I.242
- Hydrogen bonds: C:N.138, C:H.193, C:T.248, C:T.248
- Salt bridges: C:R.169
- pi-Stacking: C:Y.239
D4S.13: 16 residues within 4Å:- Chain D: V.31, N.138, L.165, D.166, R.169, H.193, G.194, D.195, V.234, V.235, A.238, Y.239, I.242, Y.247, T.248
- Ligands: NAI.11
11 PLIP interactions:11 interactions with chain D- Hydrophobic interactions: D:V.235, D:A.238, D:I.242, D:I.242
- Hydrogen bonds: D:N.138, D:H.193, D:T.248, D:T.248, D:T.248
- Salt bridges: D:R.169
- pi-Stacking: D:Y.239
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, B. et al., Structure-based Optimization of Potent, Cell-ActiveHydroxylactam Inhibitors of Lactate Dehydrogenase. To Be Published
- Release Date
- 2019-10-30
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.02 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 3 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 4 x D4S: (6R)-6-(3-aminophenyl)-3-[(2-chlorophenyl)sulfanyl]-4-hydroxy-6-(thiophen-3-yl)-5,6-dihydro-2H-pyran-2-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, B. et al., Structure-based Optimization of Potent, Cell-ActiveHydroxylactam Inhibitors of Lactate Dehydrogenase. To Be Published
- Release Date
- 2019-10-30
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D